clinical trial · NCT06792552
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube CancerRenal Cell Carcinoma (RCC)Papillary Renal Cell Carcinoma (Prcc)Uterine Serous Carcinoma (USC)NSCLC (Non-small Cell Lung Cancer)Primary Peritoneal CancerSIM0505 for injectionSIM0505 for injection
brief summary
This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
started
Feb 26, 2025
primary completion
Feb 1, 2028
completion
Aug 1, 2028
last updated
Aug 17, 2026
official title
A Phase I First-in-human, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol